Population-Based Study of the Epidemiology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection
Authors:
- 12 December 2009
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 38 (1) , 25-32
Abstract
Background: Detailed population-based data on the epidemiologyof Pseudomonas aeruginosa bloodstream infectionsare sparse. We sought to describe the incidence rate, riskfactors, and outcomes associated with P. aeruginosa bacteremiain a large Canadian health region. Patients and Methods: A retrospective population-basedsurveillance for P. aeruginosa bacteremia was conductedin the Calgary Health Region (CHR, population:approx. 1.2 million) during the period from 2000 to2006. Results: A total of 284 incident cases of P. aeruginosabacteremia were identified in CHR residents, correspondingto an annual incidence rate of 3.6/100,000.Nosocomial acquisition accounted for 45% of cases,healthcare-associated community onset for 34% of cases,and community-acquired (CA) cases for 21%. Relative tothe general population, risk factors for bloodstreaminfection included male sex, increasing age, hemodialysis,solid organ transplant, diagnosis of cancer, heartdisease, HIV infection, diabetes mellitus, and/or chronicobstructive airway disease (COPD). Overall mortality was29%. Factors associated with mortality in univariateanalysis included pulmonary focus of infection andco-morbidities, including chronic liver disease, substanceabuse, heart disease, COPD, and cancer, and increasedwith the burden of co-morbidities. Despite thosepatients with CA disease having fewer co-morbidities,they had a significantly higher mortality rate thaneither healthcare-associated cases or nosocomial cases(RR 1.88, p = 0.05). Conclusions: This study documents that P. aeruginosabacteremic disease is responsible for a significant burdenof illness in general populations and identifies thosegroups at increased risk of infection and subsequentmortality. This information can be used to identify thoseindividuals likely to benefit from empiric anti-pseudomonaltherapies.Keywords
This publication has 44 references indexed in Scilit:
- Incidence of Pseudomonas aeruginosa Bacteremia: A Population-Based StudyThe American Journal of Medicine, 2008
- Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance BreakpointClinical Infectious Diseases, 2008
- Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐ResistantPseudomonas aeruginosain the Calgary Health Region: Importance of Metallo‐β‐Lactamase (MBL)–Producing StrainsThe Journal of Infectious Diseases, 2005
- Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemiaClinical Microbiology and Infection, 2005
- Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programmeInternational Journal of Antimicrobial Agents, 2004
- Pseudomonas aeruginosaBacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical OutcomeClinical Infectious Diseases, 2003
- Population‐Based Study of the Epidemiology of and the Risk Factors for InvasiveStaphylococcus aureusInfectionsThe Journal of Infectious Diseases, 2003
- Systemic Inflammatory Response Syndrome in Adult Patients with Nosocomial Bloodstream Infection Due toStaphylococcus aureusClinical Infectious Diseases, 2001
- Invasive Group A Streptococcal Infections in Ontario, CanadaNew England Journal of Medicine, 1996
- Pseudomonas bacteremia. Retrospective analysis of 410 episodesArchives of internal medicine (1960), 1985